Related Experiment Video
Updated: Jan 2, 2026

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
Published on: October 11, 2022
The TOSCA Registry for Tuberous Sclerosis-Lessons Learnt for Future Registry Development in Rare and Complex Diseases
Ruben Marques1,2, Elena Belousova3, Mirjana P Benedik4
1Novartis Farma S.p.A., Origgio, Italy.
The Tuberous Sclerosis Complex registry (TOSCA) improved TSC knowledge and awareness. Key challenges included limited registry duration and data quality issues, highlighting the need for better patient retention and sustainability strategies for rare disease registries.
Area of Science:
- Rare disease research
- Clinical data management
- Patient registries
Background:
- Tuberous Sclerosis Complex (TSC) is a rare genetic disorder.
- International disease registries are crucial for understanding rare conditions.
- The Tuberous Sclerosis registry to increase disease Awareness (TOSCA) aimed to gather clinical data on TSC patients.
Purpose of the Study:
- To identify challenges encountered during the design, execution, and publication of the TOSCA registry.
- To derive lessons learned for future rare and complex disease registries.
- To assess the impact of the TOSCA registry on TSC knowledge and awareness.
Main Methods:
- A 225-question survey was distributed to 511 individuals involved in the TOSCA registry.
- Respondents included Scientific Advisory Board members, principal investigators, and sponsor employees.
- Data from questionnaires returned within two months were analyzed.
Main Results:
- A 10.4% response rate was achieved, with high completeness for closed questions.
- Primary issues identified were limited registry duration (38%) and missing data handling (32%).
- Over 80% reported increased knowledge of TSC natural history and manifestations, and improved disease awareness.
Conclusions:
- Patient registries are vital for increasing disease awareness and generating real-world evidence in rare diseases.
- Strategies for patient retention and long-term sustainability are essential for registry success.
- Improving data quality and mitigating biases are critical for the validity of registry findings.
More Related Videos
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Treatment Resistant Cancers